Zydus Cadila gets US approval for anti-diabetic drug sell

Zydus Cadila has received the final approval from the USFDA to market anti-diabetic drug Pioglitazone HC1 tablets in the US markets.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news